Emory University: Novel Drug Shows Promising Efficacy for Patients With Multiple Myeloma
August 03, 2022
August 03, 2022
ATLANTA, Georgia, Aug. 3 (TNSjou) -- Emory University issued the following news release:
Results of an international clinical trial co-led by researchers at Winship Cancer Institute at Emory University show potential for a novel drug to benefit patients with multiple myeloma whose disease either recurred or was resistant to three or more earlier lines of treatment.
Nearly two-thirds of the trial's participants experienced deep and durable responses from the clinica . . .
Results of an international clinical trial co-led by researchers at Winship Cancer Institute at Emory University show potential for a novel drug to benefit patients with multiple myeloma whose disease either recurred or was resistant to three or more earlier lines of treatment.
Nearly two-thirds of the trial's participants experienced deep and durable responses from the clinica . . .